A61K 38/1875
Bone morphogenic factor
Official title: {Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor}
A61K38/1875 (Bone morphogenic factor) appears on 618 US grants and 1,025 published applications in this corpus.
Search patents in A61K- Granted patents
- 618
- Published applications
- 1,025
- Assignees
- 439
- Inventors
- 1,443
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 11 | 0 |
| 1998 | 15 | 0 |
| 1999 | 11 | 0 |
| 2000 | 11 | 0 |
| 2001 | 16 | 7 |
| 2002 | 14 | 24 |
| 2003 | 9 | 31 |
| 2004 | 8 | 27 |
| 2005 | 13 | 33 |
| 2006 | 17 | 41 |
| 2007 | 13 | 45 |
| 2008 | 14 | 57 |
| 2009 | 22 | 55 |
| 2010 | 22 | 63 |
| 2011 | 19 | 59 |
| 2012 | 33 | 46 |
| 2013 | 34 | 56 |
| 2014 | 39 | 48 |
| 2015 | 24 | 47 |
| 2016 | 27 | 45 |
| 2017 | 43 | 43 |
| 2018 | 19 | 28 |
| 2019 | 31 | 54 |
| 2020 | 26 | 38 |
| 2021 | 27 | 36 |
| 2022 | 27 | 37 |
| 2023 | 12 | 31 |
| 2024 | 19 | 31 |
| 2025 | 18 | 20 |
| 2026 | 9 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of BMP9 in combination with NK cell and PD-L1 antibody in preparing medicament for treating liver cancer29 Sep 2026US 12,746,274 B2Sun Yat-Sen University
- Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration28 Jul 2026US 12,691,161 B2The Board of Trustees of the Leland Stanford Junior University
- Combined therapy for muscular diseases9 Jun 2026US 12,649,002 B2Association Institut De Myologie
- Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases2 Jun 2026US 12,642,817 B2The Johns Hopkins University
- Compositions and methods of controlling expression of thermogenin (UCP-1) in skeletal muscles5 May 2026US 12,616,735 B2
- Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration1 Oct 2026US 2026/0295008 A1
- Compositions and methods of controlling expression of thermogenin (ucp-1) in skeletal muscles10 Sep 2026US 2026/0263560 A1Thermogen Biotherapeutics, LLC
- Methods for treating neurodegenerative disorders20 Aug 2026US 2026/0240949 A1President and Fellows of Harvard College
- Substantially Monodisperse Ultrasound Responsive Nanobubble Compositions and Methods of Production and Use Thereof13 Aug 2026US 2026/0232849 A1University of Central Florida Research Foundation, Inc.
- Clay nanoparticles for medical use30 Jul 2026US 2026/0216338 A1Renovos Biologics Limited
Most cited
By later US patents
- Three dimensional cell protector/pore architecture formation for bone and tissue constructs778US 7,713,542 B2ADA Foundation · 2010
- Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor777US 8,734,831 B2Snu R&Db Foundation · 2014
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Compositions and therapeutic methods using morphogenic proteins and stimulatory factors265US 5,948,428 AStryker Corporation · 1999
- Lineage-directed induction of human mesenchymal stem cell differentiation264US 5,736,396 ACase Western Reserve University · 1998